All In Biotech

Drug Trial Radar · NCT04501874

A Study to Evaluate EMB 001 in Subjects With Cocaine Use Disorder

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Study to Evaluate the Safety and Efficacy of EMB 001 in Subjects With Moderate-to-Severe Cocaine Use Disorder

Last checked: Nov 20, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

82

Actual

Start

Jul 29, 2020

Primary completion

Jul 27, 2022

Study completion Oct 15, 2022

Sponsor

Lead sponsor
Embera NeuroTherapeutics, Inc.Industry
Sponsor type
Industry
Collaborators
National Institute on Drug Abuse (NIDA)
First posted
Aug 6, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

EMB-001 is a combination of 2 drugs: the cortisol synthesis inhibitor, metyrapone (Metopirone®), and the benzodiazepine receptor agonist, oxazepam (original trade name Serax®; now marketed as oxazepam (generic) only). This is a Phase 2 study in approximately 80 adult subjects with moderate-to-severe Cocaine Use Disorder (CUD).

Conditions

  • Cocaine Use Disorder

Interventions

  • EMB-001Drug

    720 mg metyrapone/24 mg oxazepam mg BID

  • EMB-001 PlaceboDrug

    Inactive comparator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Continuous Abstinence From Cocaine UseTime frame: Week 11 to Week 13

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Pacific Treatment and Research Center, Department of Psychiatry, University of California, San Diego, School of Medicine

    San Diego, California

  • Segal Trials

    Miami, Florida

  • U PENN- Perelman School of Medicine

    Philadelphia, Pennsylvania

  • Medical University of South Carolina

    Charleston, South Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.